/
Neurol Neuroimmunol Neuroinflamm
Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial
- P. Vermersch
- L. Brieva-Ruiz
- R.J. Fox
- F. Paul
- L. Ramio-Torrenta
- M. Schwab
- A. Moussy
- C. Mansfield
- O. Hermine
- M. Maciejowski